| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.17 | 0.02 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.088 | 0.02 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |